# Comparing the impact of systemic pituitary adenylate-cyclase-activating polypeptide (PACAP) and calcitonin gene-related peptide (CGRP) on motion-induced nausea and balance behaviors in mice

**Authors:** Shafaqat M. Rahman, Abigail Dweh, Anne E. Luebke

PMC · DOI: 10.1371/journal.pone.0334444 · PLOS One · 2025-11-18

## TL;DR

This study explores how a peptide called PACAP affects nausea and balance in mice, suggesting it may play a role in migraines.

## Contribution

The study provides preclinical evidence linking PACAP-38 to motion-induced nausea and balance issues in mice.

## Key findings

- IP PACAP-38 disrupted motion-induced thermoregulation and blunted tail vasodilation in both sexes.
- PACAP-38 increased postural sway in female mice and caused balance beam imbalances.
- PACAP-38 did not affect rotarod performance, unlike CGRP.

## Abstract

Pituitary adenylate-cyclase-activating polypeptide (PACAP), particularly its dominant isoform PACAP-38, is implicated in migraine and represents a promising therapeutic target. We investigated if intraperitoneally delivered (IP) PACAP-38 impacts motion-induced nausea, postural sway, and imbalance in C57BL/6J wildtype mice using the motion-induced thermoregulation, center of pressure (CoP), rotarod, and balance beam assays. We also assessed systemic Calcitonin Gene-Related Peptide’s (CGRP) effects on these behaviors in parallel. Our findings indicate that IP PACAP-38 significantly disrupts motion-induced thermoregulation in mice, with notable blunting of tail vasodilation responses in both sexes. Additionally, PACAP-38 administration increased postural sway in female mice only and caused balance beam imbalances. Contrary to IP CGRP, IP PACAP-38 did not affect rotarod performance when mice were trained on a dowel with 1.5 cm radius. Our findings provide preclinical evidence supporting a potential role of PACAP-38 in vestibular migraine pathophysiology. Future research will explore if PACAP antagonism can protect against PACAP-38’s effects on nausea and balance behaviors, relevant to treatment of vestibular migraine (VM), especially for patients unresponsive to triptans or CGRP-targeting therapies.

## Linked entities

- **Proteins:** ADCYAP1 (adenylate cyclase activating polypeptide 1), CALCA (calcitonin related polypeptide alpha)
- **Diseases:** migraine (MONDO:0005277)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Adcyap1 (adenylate cyclase activating polypeptide 1) [NCBI Gene 11516] {aka PACAP}
- **Diseases:** VM (MESH:D008881), nausea (MESH:D009325)
- **Chemicals:** triptans (MESH:D014363)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12626257/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12626257/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12626257/full.md

---
Source: https://tomesphere.com/paper/PMC12626257